These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 7459927)

  • 21. Relationship between epicardial ST-segment elevation and myocardial ischemic damage after experimental coronary artery occlusion in dogs.
    Heng MK; Singh BN; Norris RM; John MB; Elliot R
    J Clin Invest; 1976 Dec; 58(6):1317-26. PubMed ID: 993347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of oxyfedrin: a beta-adrenoreceptor stimulant, on infarct size following acute coronary artery ligation.
    Timogiannakis G; Petropoulos D; Toutouzas P; Courouklis C; Avgoustakis D
    Cardiovasc Res; 1978 Jun; 12(6):341-7. PubMed ID: 698986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methylprednisolone interventions in myocardial infarction: a controversial subject.
    LeGal YM; Morrissey LL
    Can J Cardiol; 1990 Nov; 6(9):405-10. PubMed ID: 2276078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Elevated Reperfusion Pressure on "No Reflow" Area and Infarct Size in a Porcine Model of Ischemia-Reperfusion.
    Pantsios C; Kapelios C; Vakrou S; Diakos N; Pozios I; Kontogiannis C; Nanas J; Malliaras K
    J Cardiovasc Pharmacol Ther; 2016 Jul; 21(4):405-11. PubMed ID: 26589289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Temporal factors in the reduction of myocardial infarct volume by methylprednisolone.
    Shatney CH; MacCarter DJ; Lillehei RC
    Surgery; 1976 Jul; 80(1):61-9. PubMed ID: 1273768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ischemic changes in the canine heart as affected by the dimethyl quaternary analog of propranolol, UM-272 (SC-27761).
    Lucchesi BR; Burmeister WE; Lomas TE; Abrams GD
    J Pharmacol Exp Ther; 1976 Nov; 199(2):310-28. PubMed ID: 978488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction of QTD--A Novel Marker of Successful Reperfusion in NSTEMI. Pathophysiologic Insights by CMR.
    Jensen CJ; Lusebrink S; Wolf A; Schlosser T; Nassenstein K; Naber CK; Sabin GV; Bruder O
    Int J Med Sci; 2015; 12(5):378-86. PubMed ID: 26005372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early ventricular fibrillation in the baboon: possible role of epicardial ST segment changes.
    Bruyneel K; Korrubel J; Opie LH
    Recent Adv Stud Cardiac Struct Metab; 1975; 5():329-33. PubMed ID: 1188165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pretreatment with the iron chelator desferrioxamine fails to provide sustained protection against myocardial ischaemia-reperfusion injury.
    Reddy BR; Wynne J; Kloner RA; Przyklenk K
    Cardiovasc Res; 1991 Sep; 25(9):711-8. PubMed ID: 1799904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduction in infarct size following experimental coronary occlusion by administration of verapamil.
    Singh BN; Smith HJ; Norris RM
    Recent Adv Stud Cardiac Struct Metab; 1975; 10():435-52. PubMed ID: 813284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The sequential changes in myocardial thickness and thickening which occur during acute transmural infarction, infarct reperfusion and the resultant expression of reperfusion injury.
    Turschner O; D'hooge J; Dommke C; Claus P; Verbeken E; De Scheerder I; Bijnens B; Sutherland GR
    Eur Heart J; 2004 May; 25(9):794-803. PubMed ID: 15120891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on experimental myocardial infarction: dogs or baboons?
    Flameng W; Vanhaecke J; Vandeplassche G
    Cardiovasc Res; 1986 Apr; 20(4):241-7. PubMed ID: 3719603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determinants of myocardial salvage during acute myocardial infarction: evaluation with a combined angiographic and CMR myocardial salvage index.
    Ortiz-Pérez JT; Lee DC; Meyers SN; Davidson CJ; Bonow RO; Wu E
    JACC Cardiovasc Imaging; 2010 May; 3(5):491-500. PubMed ID: 20466344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological evidence that inducible nitric oxide synthase is a mediator of delayed preconditioning.
    Imagawa J; Yellon DM; Baxter GF
    Br J Pharmacol; 1999 Feb; 126(3):701-8. PubMed ID: 10188982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ischaemic preconditioning by partial occlusion without intermittent reperfusion.
    Koning MM; Simonis LA; de Zeeuw S; Nieukoop S; Post S; Verdouw PD
    Cardiovasc Res; 1994 Aug; 28(8):1146-51. PubMed ID: 7954615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardioprotective effects of monophosphoryl lipid A, a novel endotoxin analogue, in the dog.
    Yao Z; Auchampach JA; Pieper GM; Gross GJ
    Cardiovasc Res; 1993 May; 27(5):832-8. PubMed ID: 8394211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Problems in assessing infarction size by epicardial mapping: preliminary studies with quinidine.
    Binetti G; Markiewicz W; Billingham M; Kernoff R; Harrison DC
    Eur J Cardiol; 1976 Dec; 4(4):429-37. PubMed ID: 1001338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protection from ischaemic-reperfusion injury with adenosine pretreatment is reversed by inhibition of ATP sensitive potassium channels.
    Toombs CF; McGee DS; Johnston WE; Vinten-Johansen J
    Cardiovasc Res; 1993 Apr; 27(4):623-9. PubMed ID: 8324796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of isoprenaline on epicardial ST-segment elevation, lactate production, and myocardial blood flow following coronary artery ligation.
    Norris RM; Smith HJ; Singh BN; Nisbet H; John MB; Hurley PJ
    Cardiovasc Res; 1975 Nov; 9(6):770-8. PubMed ID: 1203916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The novel calcium antagonist Ro 40-5967 limits myocardial infarct size in the dog.
    Vander Heide RS; Schwartz LM; Reimer KA
    Cardiovasc Res; 1994 Oct; 28(10):1526-32. PubMed ID: 8001041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.